The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Conjugated linoleic acid (CLA) refers to a group of positional and geometric isomers of linoleic acid. Studies using animal models have shown that CLA reduces adiposity, improves plasma lipoprotein metabolism and insulin sensitivity and reduces arteriosclerosis. Whilst CLA may have therapeutic potential with regard to coronary artery disease risk factors in human subjects, there has been little investigation into its effects in human subjects. This current study investigated the effects of dietary supplementation using two isomeric blends of CLA on triacylglycerol (TAG)-rich lipoprotein metabolism and reverse cholesterol transport in human subjects and evaluates whether CLA modulated cardiovascular disease risk factors. Fifty-one normolipidaemic subjects participated in this randomised double-blind placebo-controlled intervention trial. Subjects were randomly assigned to receive 3 g cis-9,trans-11–trans-10,cis-12 isomeric blend (50: 50) or a cis-9,trans-11–trans-10,cis-12 isomeric blend (80: 20) CLA or linoleic acid (control)/d for 8 weeks. The 50: 50 CLA isomer blend significantly reduced (P≤0·005) fasting plasma TAG concentrations. The 80: 20 CLA isomer blend significantly reduced (P≤0·05) VLDL-cholesterol concentrations. CLA supplementation had no significant effect on LDL-cholesterol, HDL-lipid-protein composition or reverse cholesterol transport. CLA supplementation had no effect on body weight, plasma glucose and insulin concentrations. Fatty acid analysis revealed that the cis-9,trans-11 CLA isomer was incorporated into total plasma lipids following supplementation with both isomeric blends of CLA. The present study demonstrates that CLA supplementation significantly improves plasma TAG and VLDL metabolism in human subjects. The study confirms that some of the cardio-protective effects of CLA that were shown in animal studies are relevant to man.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chin, S. F., Liu, W., Storkson, J. M., Ha, Y. L., & Pariza, M. W. (1992) · Journal of Food Composition and Analysis · doi:10.1016/0889-1575(92)90037-k · Cited by 1,197 · cited 1×
“Chin et al. (1992) estimated the daily intake of CLA in human subjects to be 160 mg/d.”
BackgroundPark, Y., Storkson, J. M., Albright, K. J., Liu, W., & Pariza, M. W. (1999) · Lipids · doi:10.1007/s11745-999-0358-8 · Cited by 815
Fruchart, J.-C., Duriez, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00007 · Cited by 425
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.
Mann, C. J., Yen, F. T., Grant, A. M., & Bihain, B. E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115535 · Cited by 339 · cited 2×
“CETP is a key enzyme which regulates reverse cholesterol transport, catalysing the reciprocal transfer of TAG and cholesteryl ester between HDL and VLDL. VLDL-TAG is an important determinant of CETP activity (Mann et al. 1991).”
Background
Cited by
Biological effects of conjugated linoleic acids in health and disease
Bhattacharya, A., Banu, J., Rahman, M., Causey, J., & Fernandes, G. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.02.009 · Cited by 662
Anand, S. S., Hawkes, C., de Souza, R. J., Mente, A., Dehghan, M., Nugent, R., Zulyniak, M. A., Weis, T., Bernstein, A. M., Krauss, R. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.050 · Cited by 507
den Hartigh, L. (2019) · Nutrients · doi:10.3390/nu11020370 · Cited by 371
“[208] Normolipidemic men and women (n = 57).”
BackgroundImplication of Conjugated Linoleic Acid (CLA) in Human Health
Dilzer, A., & Park, Y. (2012) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.501409 · Cited by 375
Perspective on the safety and effectiveness of conjugated linoleic acid
Pariza, M. W. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.1132s · Cited by 351
Brouwer, I. A., Wanders, A. J., & Katan, M. B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009434 · Cited by 317
“If we excluded the study that investigated these CLA isomers separately [58] and the two interventions that used CLA with an 80:20 ratio of the cis-9, trans-11 and trans-10, cis-12 isomers [27,52], the effect of CLA on the LDL to HDL ratio became 0.”
MethodConjugated linoleic acid and obesity control: efficacy and mechanisms
Wang, Y. W., & Jones, P. J. H. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802641 · Cited by 312
Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans
Whigham, L. D., Watras, A. C., & Schoeller, D. A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1203 · Cited by 312
Tricon, S., Burdge, G. C., Kew, S., Banerjee, T., Russell, J. J., Jones, E. L., Grimble, R. F., Williams, C. M., Yaqoob, P., & Calder, P. C. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.614 · Cited by 294
Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans
Gaullier, J.-M., Halse, J., Høye, K., Kristiansen, K., Fagertun, H., Vik, H., & Gudmundsen, O. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.1118 · Cited by 292
Conjugated linoleic acids as functional food: an insight into their health benefits
Benjamin, S., & Spener, F. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-36 · Cited by 273
Gaullier, J.-M., Halse, J., Høye, K., Kristiansen, K., Fagertun, H., Vik, H., & Gudmundsen, O. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.4.778 · Cited by 269
Moloney, F., Yeow, T.-P., Mullen, A., Nolan, J. J., & Roche, H. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.887 · Cited by 247
Self-citationEffect of CLA supplementation on immune function in young healthy volunteers
Song, H.-J., Grant, I., Rotondo, D., Mohede, I., Sattar, N., Heys, S. D., & Wahle, K. W. J. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602102 · Cited by 162
“In another human trial (Noone et al, 2002) showed that CLA supplementation (3 g/ day, 80:20 of CLA 9–11 and 10–12 isomeric blend) significantly reduced VLDL-cholesterol concentrations (Noone et al, 2002).”
BackgroundConjugated linoleic acid isomers: differences in metabolism and biological effects
Churruca, I., Fernández‐Quintela, A., & Portillo, M. P. (2009) · BioFactors · doi:10.1002/biof.13 · Cited by 160
‘Browning’ the cardiac and peri-vascular adipose tissues to modulate cardiovascular risk
Aldiss, P., Davies, G., Woods, R., Budge, H., Sacks, H. S., & Symonds, M. E. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.074 · Cited by 148
Conjugated linoleic acid and inflammatory cell signalling
Reynolds, C. M., & Roche, H. M. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1016/j.plefa.2010.02.021 · Cited by 118
The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers
Nugent, A. P., Roche, H. M., Noone, E. J., Long, A., Kelleher, D. K., & Gibney, M. J. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602132 · Cited by 71
Self-citationConjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics
MacRedmond, R., Singhera, G., Attridge, S., Bahzad, M., Fava, C., Lai, Y., Hallstrand, T. S., & Dorscheid, D. R. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03531.x · Cited by 49
Mullen, A., Moloney, F., Nugent, A. P., Doyle, L., Cashman, K. D., & Roche, H. M. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.12.008 · Cited by 37
Metadata
- Authors
- Noone, E. J., Roche, H. M., Nugent, A. P., & Gibney, M. J.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2002-09
- Volume
- 88
- Issue
- 3
- Pages
- 243-251
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2004306309
- Cited by
- 240
- References
- 4
- FWCI
- 14.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.